Clinical Trial

The Effect of Beta-glucan in Non-Small Cell Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 10, 2025 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2008-05-20; most recent amendment 2025-01-09.
Trial Details
NCT Number NCT00682032
Lead Sponsor University of Louisville
Collaborators: James Graham Brown Cancer Center
Conditions Non Small Cell Lung Cancer
Enrollment 300 participants
Start Date 2008-10
Primary Completion 2025-04 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2025-01-10